Help accelerate Southern Research's work against COVID-19.
Learn More
College students from across the U.S. are getting firsthand experience with the innovative work conducted at Southern Research in the latest generation of the nonprofit’s internship program. Interns from Princeton […]
Southern Research has been awarded a new, five-year Indefinite-Delivery Indefinite-Quantity (IDIQ) contract from the National Cancer Institute to investigate the pharmacokinetic properties of antitumor and other therapeutic agents of interest […]
In 2014, Southern Research received funding from the National Institute of Allergies and Infectious Diseases (NIAID) through a multi-center U19 grant (U19AI109680) administered by the University of Alabama at Birmingham […]
Southern Research scientists joined the front lines in the battle against HIV/AIDS in 1986, not long after the deadly viral infection emerged as a terrifying new public health threat in […]
Poliomyelitis is a crippling and potentially fatal disease caused by a virus. As recently as 60 years ago, there were few diseases more frightening to parents of young children than […]
In a message to mark Southern Research’s 75th anniversary, Dr. Francis S. Collins, director of the National Institutes of Health, praised the organization’s scientists for making significant advances against cancer […]
Southern Research has been awarded a five-year IDIQ contract with a potential value of $19 million from the National Cancer Institute (NCI) to study the preclinical toxicology of new drugs […]
Southern Research is pleased to announce the hiring of Greg Furrow as Vice President of Quality and Compliance. As vice president, Furrow joins the executive team, and in addition to […]
“To borrow a line from Jurassic Park, life finds a way.” – Jim Pannucci, Ph.D., senior director of Infectious Disease Research at Southern Research. Pannucci appeared on the Bio Report podcast with […]
Infectious disease research veteran Jim Pannucci, Ph.D., has joined Southern Research as senior director for infectious disease research, the largest focus area within the organization’s Drug Development division. In this […]